Chronic Kidney Disease Market Analysis, Demand And Outlook 2025- 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Current Size and Annual Growth Rate of the Chronic Kidney Disease Market?
The chronic kidney disease market size has grown strongly in recent years. It will grow from $70.65 billion in 2024 to $74.87 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to hypertension and diabetes epidemic, aging population, unhealthy lifestyles, healthcare access disparities, medical advances.

The chronic kidney disease market size is expected to see strong growth in the next few years. It will grow to " $95.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to healthcare policy focus, precision medicine development, rise in obesity rates, growth in chronic diseases, improved healthcare access. Major trends in the forecast period include early screening campaigns, telemedicine and remote monitoring, patient empowerment programs, community-based care initiatives, nutritional therapy integration.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What Are the Primary Factors Driving the Chronic Kidney Disease Market?
The increasing prevalence of kidney disease is expected to propel the growth of the chronic kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Medication for kidney disease is used to control blood pressure in patients and decrease protein loss to halt the progression of kidney impairment, manage symptoms, and avoid consequences. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 15%, or 37 million people in the US, were affected by kidney disease. Therefore, the increasing prevalence of kidney disease is driving the growth of the chronic kidney disease market.

How Is the Chronic Kidney Disease Market Categorized Based on Key Segments?
The chronic kidney diseasemarket covered in this report is segmented –

1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy
2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments
3) By Route of Administration: Oral; Intravenous; Subcutaneous
4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users

Subsegments:
1) By Blood Test: Serum Creatinine Test; Glomerular Filtration Rate (GFR) Test; Blood Urea Nitrogen (BUN) Test; Electrolyte Tests
2) By Urine Test: Urinalysis; 24-hour Urine Collection; Urine Protein Test; Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound; CT Scan; MRI; X-ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy; Open Kidney Biopsy; Laparoscopic Kidney Biopsy

Which Future-Ready Trends Are Expected to Influence the Chronic Kidney Disease Market?
Product innovations are a key trend gaining popularity in the chronic kidney disease market. Companies operating in the chronic kidney disease market are developing innovative products to sustain their position in the market. For instance, in August 2022, Bayer, a Germany-based biotechnology and pharmaceutical company, launched the innovative medicine Kerendia (finerenone) to slow down the progression of chronic kidney disease in diabetes patients. It is a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist and differs from existing treatments. It blocks mineralocorticoid receptor (MR) overactivation, contributing to CKD progression and cardiovascular damage.

Who Are the Major Companies Operating in the Chronic Kidney Disease Market?
Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Get the detailed chronic kidney disease market report today
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Region Holds the Largest Share of the Chronic Kidney Disease Market?
North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more